StemCellPatents.com Newsletter

Hello manoj kumar valluru,

A publication in the Journal of Immunology co-authored by University of Western Ontario and Medistem Inc's Thomas Ichim successfully used third-party bone grafts to prevent acute antibody mediated immune rejection in an aggressive cardiac transplant model, possibly through mesenchymal stem cells.  The immune modulatory component was radioresistant and bone marrow mononuclear cells had no effect. 

Novocell scored another patent victory, # 7,534,608, covering about 394 ways of making insulin secreting cells from ES cells. This adds to Novocell's uncomparable IP portfolio that extends to the endoderm itself !

Another patent was issued in the area of diabetes, #7,537,756 covering ways of expanding donor islets and islet-like cells for allo or xeno transplantation. 

Methods of producing pancreatic hormones     Patent Number: 7,534,608 Assignee | Inventor The company Novocell (merged from Cythera, BresaGen, and Novocell) has been strategically developing an IP portfolio covering numerous aspects of treating diabetes.  Having IP on endoderm, as well as encapsulation technologies, the company recently was issued the current patent covering generation...[Read More] Ask a question OR leave your comments.

Free bone allograft prevents acute immune reaction Tuesday May 26th, 2009 @ 22:40:47 EST London, Canada - Antibody-mediated acute vascular rejection (AVR) is a major problem in organ transplantation.  The C3H to BALB/c heterotopic (second heart) cardiac transplant model resembles the human condition of AVR.  When recipients are given a course of the conventionally used immune suppressant agent cyclosporin A, grafts...[Read More] 1 Comment Ask a question OR leave your comments. Read more StemCellPatents.com News

Media Partnerships (NEW)

RECENTLY ADDED PATENTS     Mammary stem cell marker (7,563,619) Assignee | Inventor | Ask a question OR leave your comments     Soft tissue repair and regeneration using postpartum-derived cells (7,560,276) Assignee | Inventor | Ask a question OR leave your comments     Compositions and methods for generating skin (7,560,275) Assignee | Inventor | Ask a question OR leave your comments     Method for reducing neuronal degeneration so as to ameliorate the effects of injury or disease (7,560,102) Assignee | Inventor | Ask a question OR leave your comments     Human cord blood derived unrestricted somatic stem cells (USSC) (7,560,280) Assignee | Inventor | Ask a question OR leave your comments     Human cord blood derived unrestricted somatic stem cells (USSC) (7,556,801) Assignee | Inventor | Ask a question OR leave your comments     Dedifferentiated, programmable stem cells of monocytic origin, and their production and use (7,553,663) Assignee | Inventor | Ask a question OR leave your comments     Stromal antigen-presenting cells and use thereof (7,553,661) Assignee | Inventor | Ask a question OR leave your comments     Directed in vitro differentiation of marrow stromal cells into neural cell progenitors (7,547,545) Assignee | Inventor | Ask a question OR leave your comments     Progenitor cells from wharton's jelly of human umbilical cord (7,547,546) Assignee | Inventor | Ask a question OR leave your comments     View all 1436 Stem Cell Patents on StemCellPatents.com

LATEST NEWS     Leptin Blocks T Regulatory Cell Expansion August 23rd, 2009     Mechanism of Multiple Sclerosis Stem Cell Therapy July 24th, 2009 : 2 Comments     Lithium for Treatment of Multiple Sclerosis July 15th, 2009     Treatment of Degenerative Disc Disease by Bone Marrow Stem Cells July 9th, 2009 : 2 Comments     Apoptotic Cells Secrete Angiogenic Factors June 27th, 2009     Read more news on StemCellPatents.com

LATEST JOBS POSTS     View the StemCellPatents.com Job Board

Thanks again for your help in supporting StemCellPatents.com.

Media Partnerships (NEW)

(BETA)